Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zymeworks Inc. Director's Dealing 2026

Jan 13, 2026

32180_dirs_2026-01-12_ee06083f-772d-4a96-a182-ecab076d3b1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2026-01-12

Reporting Person: Neu Kelvin (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-01-12 Stock Option (Right to Buy) $23.16 A 11500 Acquired 2036-01-11 Common Stock (11500) Direct
2026-01-12 Restricted Stock Unit $ A 7700 Acquired 2027-01-12 Common Stock (7700) Direct

Footnotes

F1: Stock options vest on January 12, 2027.

F2: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of common stock.

F3: RSUs vest on January 12, 2027.